Peter Attia· MD
what I would say is probably a little more more in the near term on the clinical treatment because I think we can make more rapid gains in that while we need some slower longer term assessment of the others but also I would amp up the the non-pharmaceutical non-clinical non surgery a little bit the funding from the government